Why the study?
There are few data on permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation for bicuspid aortic valve stenosis.
What are the incidence and predictors of permanent pacemaker implantation after TAVI with a balloon-expandable device in patients with bicuspid aortic valves?
What are the incidence and predictors of permanent pacemaker implantation after TAVI with a balloon-expandable device in patients with bicuspid aortic valves?
Answers are grounded in this paper and cite their sources.
Preprocedural RBBB and shorter MS are independent predictors of permanent pacemaker implantation after balloon-expandable TAVI in patients with bicuspid aortic valves.
Introduction: There are few data on permanent pacemaker implantation (PPMI) in patients who have undergone transcatheter aortic valve implantation (TAVI) for bicuspid aortic valve (BAV) stenosis. Aim: The purpose of this study was to evaluate the predictors and incidence of PPMI in bicuspid patients using a balloon-expandable (BE) TAVI device. Material and methods: A total of 62 patients with bicuspid morphology who had undergone successful TAVI using a BE device without previous PPMI were included (retrospectively). Their baseline clinical, electrocardiographic (ECG), echocardiographic, and multislice computed tomography (MSCT) details were collected. Conclusions: Preprocedural RBBB on ECG and shorter MS are independent risk factors for PPMI after TAVI in BAV patients and these parameters should be considered before the procedure to guide clinical decision making. Type 1 L-R patients may be considered at increased risk of PPMI.
No takes yet. Share an insight, caveat, or question.
Süygün et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: